According to latest analysis, the global lung cancer genomic testing market was USD 1,515.0 million in 2022 and is expected to reach USD 2,762.4 million in 2029 and register a CAGR
Request for updated version of the report at the same price
Request for updated version of the report at the same price
Request for updated version of the report at the same price
Request for updated version of the report at the same price
Request for updated version of the report at the same price
Lung cancer genomic testing is a type of genetic testing that screens tumors for changes or mutations in their DNA. It helps to identify specific genomic alterations in tumor cells, which can be useful for identifying targeted treatments that may be more effective than chemotherapy or radiation. The process of lung cancer genomic testing usually involves taking a small sample of tumor tissue, which is then analyzed through various techniques like next-generation sequencing (NGS) or polymerase chain reaction (PCR). These techniques help to identify genetic mutations or alterations in the tumor DNA that may be driving cancer growth. According to latest analysis, the global lung cancer genomic testing market was USD 1,515.0 million in 2022 and is expected to reach USD 2,762.4 million in 2029 and register a CAGR of 8.96% during the forecast period, 2023-2029.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global lung cancer genomic testing market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleCustomise your report by selecting specific countries or regions
Specify Scope NowOne individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
We offer 10% Free Customization at the time of purchase
Get Free CustomizationWe sent OTP in your email & phone
Check your spam/junk folder as well
We are friendly and approachable, give us a call.
We use cookies to ensure you get the best experience on our website.